Canadian Drugmaker Apotex Seeks Up to $730 Million in First-Half IPO
February 23, 2026 at 09:20 PM
By Paula Sambo, Christine Dobby
Canadian generic drug manufacturer Apotex Inc. is looking at the first half of the year for an initial public offering in Toronto that could raise as much as C$1 billion ($730 million), according to people familiar with the matter.
đź’ˇAnalysis & Context
Canadian generic drug manufacturer Apotex Inc Canadian generic drug manufacturer Apotex Inc. is looking at the first half of the year for an initial public offering in Toronto that could raise as Monitor developments in Canadian for further updates.
đź“‹ Quick Summary
Canadian generic drug manufacturer Apotex Inc is looking at the first half of the year for an initia
Canadian generic drug manufacturer Apotex Inc. is looking at the first half of the year for an initial public offering in Toronto that could raise as much as C$1 billion ($730 million), according to people familiar with the matter.
Share:
Original Source:
Read full article at sourceHelp us improve this article. Share your feedback and suggestions.
